Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial

BACKGROUND: Allergen specific immunotherapy (AIT) in elderly patients is controversial, and there is still little evidence supporting the safety and efficacy of this treatment in this population. The study objective was to evaluate the safety and efficacy of AIT for house dust mite allergens in pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Bożek, Andrzej, Kołodziejczyk, Krzysztof, Kozłowska, Renata, Canonica, Giorgio Walter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709914/
https://www.ncbi.nlm.nih.gov/pubmed/29214012
http://dx.doi.org/10.1186/s13601-017-0180-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709914/
https://www.ncbi.nlm.nih.gov/pubmed/29214012
http://dx.doi.org/10.1186/s13601-017-0180-9

Ejemplares similares